The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Another person has joined the nearly 150 lawsuits in multi district litigation involving Johnson & Johnson’s antibiotic drug Levaquin. An elderly man alleges that Levaquin caused him to suffer a ruptured tibial tendon.

William Dowling filed a lawsuit Thursday against J&J and its units Ortho McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research and Development LLC.

The complaint alleges that the phamacuetical companies were negligent, failed to warn the public about issues with the drug, and breached implied and express warranties in the making, marketing and sales of Levaquin.

Levaquin, generic know as levofloxacin, is approved for the treatment of a variety of infections. The lawsuits allege Levaquin causes tendon injuries, including tendon rupture. Adults 60 and older or others on corticosteroid therapy are especially prone to injury.

A trial date is set for August 2010.

In July 2008, the U.S. Food and Drug Administration called for a boxed warning on Levaquin. The announcement came after several requests from the consumer advocacy group Public Citizen to add warnings.

Additionally, our firm is invesigating cases that involve Levaquin and the onset of Stevens Johnson Syndrome commonly known as SJS as well as Toxic Epidemal Necrosis or TEN. If you or a loved one experiences these problems, seek medical help immediately.

Comments are closed.

Of Interest